Evidence map›Paper›PMID 27465114›Full record

ArticlePlant physiology2016

Codon Optimization to Enhance Expression Yields Insights into Chloroplast Translation.

Kwang-Chul Kwon, Hui-Ting Chan, Ileana R León, Rosalind Williams-Carrier, Alice Barkan, Henry Daniell

Open access · bronzeAbstract read
In one paragraph

Article in Plant physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. TheGenes · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Optimized expression of human interleukin-15 inBiotechnology reports (Amsterdam, Netherlands) · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Codon Bias of theInternational journal of molecular sciences · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Kwang-Chul KwonDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6030 (K.-C.K., H.-T.C., H.D.);Global Research, Novo Nordisk, Malov DK-2760, Denmark (I.R.L.); andInstitute of Molecular Biology, University of Oregon, Eugene, Oregon 97403-1229 (R.W.-C., A.B.).ORCID 0000-0002-4037-1776
Hui-Ting ChanDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6030 (K.-C.K., H.-T.C., H.D.);Global Research, Novo Nordisk, Malov DK-2760, Denmark (I.R.L.); andInstitute of Molecular Biology, University of Oregon, Eugene, Oregon 97403-1229 (R.W.-C., A.B.).
Ileana R LeónDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6030 (K.-C.K., H.-T.C., H.D.);Global Research, Novo Nordisk, Malov DK-2760, Denmark (I.R.L.); andInstitute of Molecular Biology, University of Oregon, Eugene, Oregon 97403-1229 (R.W.-C., A.B.).ORCID 0000-0001-7319-2080
Rosalind Williams-CarrierDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6030 (K.-C.K., H.-T.C., H.D.);Global Research, Novo Nordisk, Malov DK-2760, Denmark (I.R.L.); andInstitute of Molecular Biology, University of Oregon, Eugene, Oregon 97403-1229 (R.W.-C., A.B.).
Alice BarkanDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6030 (K.-C.K., H.-T.C., H.D.);Global Research, Novo Nordisk, Malov DK-2760, Denmark (I.R.L.); andInstitute of Molecular Biology, University of Oregon, Eugene, Oregon 97403-1229 (R.W.-C., A.B.).
Henry DaniellDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6030 (K.-C.K., H.-T.C., H.D.);Global Research, Novo Nordisk, Malov DK-2760, Denmark (I.R.L.); andInstitute of Molecular Biology, University of Oregon, Eugene, Oregon 97403-1229 (R.W.-C., A.B.) hdaniell@upenn.edu.ORCID 0000-0003-4485-1176
University of Oregon · USUniversity of Pennsylvania · US

Funding

Oral immune modulatory therapy using antigens bioencapsulated in plant cellsR01HL107904 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI DANIELL, HENRY · 2011 to 2023
$7.5M
Oral Therapy for Hemophilia AR01HL109442 · NHLBI · UNIVERSITY OF FLORIDA · PI DANIELL, HENRY, HERZOG, ROLAND W. · 2011 to 2015
$3.5M
Expression of Human Therapeutic Proteins in Transgenic Tobacco ChloroplastsR01GM063879 · NIGMS · UNIVERSITY OF CENTRAL FLORIDA · PI DANIELL, HENRY · 2002 to 2010
$2.0M
Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cellsR01EY024564 · NEI · UNIVERSITY OF FLORIDA · PI DANIELL, HENRY, LI, QIUHONG · 2015 to 2018
$1.6M
NEI NIH HHS R01 EY024564NHLBI NIH HHS R01 HL107904NHLBI NIH HHS R01 HL109442NIGMS NIH HHS R01 GM063879
6 · The paper itself

Abstract

Codon optimization based on psbA genes from 133 plant species eliminated 105 (human clotting factor VIII heavy chain [FVIII HC]) and 59 (polio VIRAL CAPSID PROTEIN1 [VP1]) rare codons; replacement with only the most highly preferred codons decreased transgene expression (77- to 111-fold) when compared with the codon usage hierarchy of the psbA genes. Targeted proteomic quantification by parallel reaction monitoring analysis showed 4.9- to 7.1-fold or 22.5- to 28.1-fold increase in FVIII or VP1 codon-optimized genes when normalized with stable isotope-labeled standard peptides (or housekeeping protein peptides), but quantitation using western blots showed 6.3- to 8-fold or 91- to 125-fold increase of transgene expression from the same batch of materials, due to limitations in quantitative protein transfer, denaturation, solubility, or stability. Parallel reaction monitoring, to our knowledge validated here for the first time for in planta quantitation of biopharmaceuticals, is especially useful for insoluble or multimeric proteins required for oral drug delivery. Northern blots confirmed that the increase of codon-optimized protein synthesis is at the translational level rather than any impact on transcript abundance. Ribosome footprints did not increase proportionately with VP1 translation or even decreased after FVIII codon optimization but is useful in diagnosing additional rate-limiting steps. A major ribosome pause at CTC leucine codons in the native gene of FVIII HC was eliminated upon codon optimization. Ribosome stalls observed at clusters of serine codons in the codon-optimized VP1 gene provide an opportunity for further optimization. In addition to increasing our understanding of chloroplast translation, these new tools should help to advance this concept toward human clinical studies.

Indexed as

Gene ExpressionAmino Acid SequenceBase SequenceBlotting, NorthernBlotting, WesternChloroplastsCodonHumansLactucaNicotianaPhotosystem II Protein ComplexPlants, Genetically ModifiedProtein BiosynthesisProteomeProteomicsRibosomesCodonPhotosystem II Protein ComplexProteome

Identifiers

PMID27465114
PMCPMC5074611
OpenAlexW2500352355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.